Metered dose inhalers free of chlorofluorocarbons
نویسندگان
چکیده
منابع مشابه
Metered-dose inhalers, dry powder inhalers, and transitions.
Since 1956, the pMDI has become the most commonly prescribed and used aerosol device in the world. While concerns about global warming have led to a worldwide ban of CFCs, new HFA-propelled pMDIs are in development, requiring an evolutionary transition in the technology. The phase-out of CFC-propelled pMDIs has stimulated the development of more efficient DPIs, but issues such as cost of device...
متن کاملMetered-dose inhalers and dry powder inhalers in aerosol therapy.
Inhaled drug delivery is an important part of the armamentarium of clinicians caring for patients with pulmonary disease. An increasing variety of metered-dose inhalers and dry powder inhalers are becoming available. This has been driven by the development of new formulations and the impending ban on chlorofluorocarbon propellants. The result is a proliferation of devices, resulting in a confus...
متن کاملMetered dose inhalers and spacer devices.
Easy to carry, highly effective and extremely safe, allowing accurate, consistent dose delivery, metered dose inhalers are the inhalation devices doctors and patients choose most readily the world over. Clinical response, however, may be affected by the inhalation technique used and the precise formulation in the canisters. The purpose of this review is to consider metered dose inhalers, add on...
متن کاملWet nebulizers vs metered dose inhalers.
be developed before transferring patients from ICU to other areas offering lower levels of intensive care" is appropriate. Our article, however, focused on the need to develop criteria that can be applied to presenting patients to evaluate whether or not they would benefit from ICU, or if, in fact they would progress equally well or better in an alternative setting with less intensive levels of...
متن کاملReplacement of Chlorofluorocarbons (cfc) in Metered Dose Inhalation Products
Additional Notes This guideline is intended to facilitate companies in compiling the dossier for submission for the replacement of a CFC propellant in an already authorised medicinal product. It identifies the considerations of quality, safety and efficacy which should be taken into account. The need for this guideline has been accentuated by the imminent lack of availability of existing replac...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1995
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.310.6981.684